Abstract 7021: Discovery of a highly potent and orally bioavailable ER PROTAC degrader for the treatment of breast cancer

Authors: Guan Zhou, Yuanli Wang, Wei Xue, Yongzheng Ding, Jing Cheng, Kanghua Wang, Weiwei Yu, Wenmin Chen, Fuming Xu

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-7021

Source: Full article